WithdrawnPhase 1NCT04073472
Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's
Studying Anal fistula
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Cleveland Clinic
- Principal Investigator
- Amy Lightner, MDThe Cleveland Clinic
- Intervention
- mesenchymal stem cells (MSCs)(drug)
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2021 – 2023
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04073472 on ClinicalTrials.govOther trials for Anal fistula
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07519850The Impact of Perianal Disease on Patient's Sex LifeAHEPA University Hospital
- RECRUITINGNANCT07520500IFOC Compared With LIFT in High Anal FistulaCairo University
- RECRUITINGNCT07477496Recurrence and Anal Fistula Patient Reported Outcomes TrialNational and Kapodistrian University of Athens
- RECRUITINGNANCT07334678TROPIS Versus Coring Out Fistulectomy in High Anal FistulaCairo University
- RECRUITINGNANCT07399353Comparative Study: Fistula Rerouting vs. LIFT for High Perianal FistulaCairo University
- ENROLLING BY INVITATIONEARLY PHASE1NCT07128953Study on the Mechanism of Zuoqing San Promoting Postoperative Wound Healing of Anal Fistula by Inhibiting ROS-dependent NETosisThe Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
- RECRUITINGNANCT07081373Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients.Sixth Affiliated Hospital, Sun Yat-sen University
- RECRUITINGNCT07021742BioHealx® Anal Fistula Device Post Market Surveillance StudySignum Surgical USA Inc.